We are live on ! Find out more
KXA

KPCB XV Associates Portfolio holdings

AUM $35.8M
1-Year Est. Return 57.59%
This Fund
S&P 500
This Quarter Est. Return
-5.45%
1 Year Est. Return
-57.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$134M
AUM Growth
-$90.1M
Cap. Flow
-$79.4M
Cap. Flow %
-59.31%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
UPST icon
Upstart Holdings
UPST
+$79.4M

Sector Composition

Rank Sector Weight
1 Healthcare 55.17%
2 Technology 44.83%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWLO icon
1
Twilio
TWLO
$29.8B
$60M 44.83%
188,160
RAPT
2
DELISTED
RAPT Therapeutics
RAPT
$40.3M 30.08%
162,133
ATRA icon
3
Atara Biotherapeutics
ATRA
$74.7M
$33.6M 25.09%
75,066
UPST icon
4
Upstart Holdings
UPST
$2.8B
-635,841
Closed -$79.4M

Similar funds

KPCB XV Associates's Q3 2021 Portfolio in Review

As of Q3 2021, KPCB XV Associates held 4 positions worth $134M, down 40% from $224M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XV Associates withdrew a net $79.4M in Q3 2021, closing 1 position. Its most notable exit was Upstart Holdings, an estimated $79.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • KPCB XV Associates fully exited Upstart Holdings in Q3 2021, selling an estimated $79.4M.
  • KPCB XV Associates's ten largest holdings make up 100% of its $134M portfolio in Q3 2021.
  • KPCB XV Associates opened 0 new positions and closed 1 in Q3 2021.
  • KPCB XV Associates's portfolio value fell 40% quarter-over-quarter to $134M.

Based on KPCB XV Associates's 13F filing for Q3 2021, filed 25 Oct 2021.